Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and IrinotecanChiara Cremolini, Daniele Santini, Filippo Pietrantonio et al.|JAMA Oncology|2018Cited by 418
MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemnessMargherita Puppo, Philippe Clézardin, Manoj K. Valluru et al.|British Journal of Cancer|2023Cited by 8
Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasisMargherita Puppo, Philippe Clézardin, Martine Croset et al.|Breast Cancer Research|2024Cited by 8
Effectiveness comparison of palbociclib, ribociclib and abemaciclib in patients with HR+/HER2- aBC: Updated results from the real-world, Italian study PALMARES-2.Claudio Vernieri, Maria Vittoria Dieci, Roberta Caputo et al.|Journal of Clinical Oncology|2025Cited by 1